Douglas J Veale Selected Research

Douglas J Veale Research Topics

Disease

41	Rheumatoid Arthritis 11/2023 - 01/2002
26	Arthritis (Polyarthritis) 02/2024 - 01/2002
22	Inflammation (Inflammations) 02/2024 - 02/2002
19	Psoriatic Arthritis 01/2021 - 02/2003
15	Hypoxia (Hypoxemia) 05/2019 - 09/2009
12	Necrosis 01/2020 - 01/2009
8	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2019 - 08/2005
6	Synovitis 01/2020 - 11/2003
6	Fatigue 01/2018 - 01/2011
5	Rheumatic Diseases (Rheumatism) 12/2020 - 12/2013
5	Giant Cell Arteritis (Horton Disease) 01/2019 - 09/2015
5	Disease Progression 01/2018 - 09/2011
5	Pain (Aches) 10/2017 - 01/2010
4	Wounds and Injuries (Trauma) 01/2021 - 11/2011
3	Neoplasms (Cancer) 01/2021 - 01/2005
3	Arthralgia (Joint Pain) 01/2021 - 01/2017
3	Osteoarthritis 01/2020 - 01/2009
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2017 - 08/2011
2	Experimental Arthritis 02/2024 - 12/2014
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2019
2	Atherosclerosis 01/2019 - 09/2015
2	Vasculitis (Vasculitides) 12/2018 - 12/2018
2	Hyperplasia 01/2018 - 11/2003
2	Chronic Disease (Chronic Diseases) 01/2018 - 02/2002
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018 - 12/2006
2	Pulmonary Arterial Hypertension 11/2013 - 11/2013
2	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2013 - 11/2013
2	Telangiectasis (Telangiectasia) 11/2013 - 11/2013
1	Type 2 Diabetes Mellitus (MODY) 11/2023
1	Non-Radiographic Axial Spondyloarthritis 07/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023
1	COVID-19 01/2021
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2021
1	Cytopenia 10/2020
1	Insulin Resistance 01/2020

Drug/Important Bio-Agent (IBA)

15	CytokinesIBA 01/2021 - 06/2006
15	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2003
12	Proteins (Proteins, Gene)FDA Link 02/2024 - 02/2003
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2024 - 11/2003
6	AutoantibodiesIBA 11/2020 - 12/2006
6	Tumor Necrosis Factor InhibitorsIBA 10/2019 - 01/2011
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 02/2003
6	C-Reactive ProteinIBA 07/2016 - 11/2003
5	ametantrone (HAQ)IBA 07/2023 - 01/2010
5	LigandsIBA 01/2021 - 11/2010
5	Antirheumatic Agents (DMARD)IBA 01/2021 - 01/2002
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2019 - 04/2010
5	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2016 - 01/2006
5	Oxygen (Dioxygen)IBA 12/2014 - 03/2010
4	Interleukin-17 (Interleukin 17)IBA 02/2024 - 01/2009
4	MicroRNAs (MicroRNA)IBA 01/2021 - 09/2019
4	ChemokinesIBA 01/2021 - 06/2010
4	InterleukinsIBA 01/2020 - 01/2016
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 04/2010
4	Acute-Phase Proteins (Acute-Phase Protein)IBA 12/2018 - 01/2006
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 08/2011
4	Toll-Like Receptor 2IBA 01/2016 - 01/2011
4	Small Interfering RNA (siRNA)IBA 06/2015 - 07/2012
4	Messenger RNA (mRNA)IBA 12/2014 - 02/2003
3	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 02/2002
3	Oncostatin MIBA 01/2019 - 10/2006
3	EnzymesIBA 12/2018 - 11/2011
3	Factor VIII (Coagulation Factor VIII)IBA 01/2018 - 07/2012
3	Rheumatoid FactorIBA 01/2017 - 05/2007
3	Immunoglobulin G (IgG)IBA 06/2015 - 02/2011
3	Collagen Type II (Type II Collagen)IBA 04/2012 - 11/2003
3	NF-kappa B (NF-kB)IBA 09/2009 - 01/2006
2	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2020
2	Interleukin-12 (IL 12)IBA 01/2020 - 12/2018
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2020 - 12/2014
2	tofacitinibIBA 10/2019 - 12/2018
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2019 - 01/2019
2	Ustekinumab (CNTO 1275)FDA Link 12/2018 - 01/2016
2	Interleukin-23 (Interleukin 23)IBA 12/2018 - 01/2016
2	AntibodiesIBA 01/2018 - 11/2011
2	Anti-Citrullinated Protein AntibodiesIBA 11/2017 - 01/2017
2	acetyl 4-aminosalicylic acidIBA 11/2017 - 01/2017
2	Janus KinasesIBA 01/2017 - 01/2016
2	Matrix Metalloproteinases (MMPs)IBA 06/2015 - 04/2012
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 06/2013 - 07/2012
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 06/2013 - 07/2012
2	ImmunosorbentsIBA 04/2012 - 11/2011
2	Mitochondrial DNA (mtDNA)IBA 04/2012 - 08/2011
2	Interleukin-8 (Interleukin 8)IBA 02/2011 - 04/2010
2	CollagenIBA 09/2007 - 11/2003
1	Therapeutic UsesIBA 11/2023
1	Glutamate DehydrogenaseIBA 11/2023
1	CanagliflozinIBA 11/2023
1	SodiumIBA 11/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2023
1	SymportersIBA 11/2023
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 07/2023
1	TOR Serine-Threonine KinasesIBA 01/2023
1	Interferon Type IIBA 01/2023
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2020
1	GlucocorticoidsIBA 01/2020

Therapy/Procedure

20	Therapeutics 11/2023 - 02/2002
10	Biological Therapy 01/2021 - 09/2007
1	Injections 01/2020